Date Founded
1999

Innovation
CVA develops proprietary, minimally invasive medical devices that assist in a patented surgical procedure intended to reduce the incidence of stroke and thromboembolism associated with atrial fibrillation (AF).

Funding
CVA has raised a total of $4.4 million investment capital to date.

Contact
2750 Premiere Parkway, Suite 200
Duluth, GA 30097
678.417.7626 phone
678.417.7325 fax